DE60019954T2 - Fab i hemmer - Google Patents

Fab i hemmer Download PDF

Info

Publication number
DE60019954T2
DE60019954T2 DE60019954T DE60019954T DE60019954T2 DE 60019954 T2 DE60019954 T2 DE 60019954T2 DE 60019954 T DE60019954 T DE 60019954T DE 60019954 T DE60019954 T DE 60019954T DE 60019954 T2 DE60019954 T2 DE 60019954T2
Authority
DE
Germany
Prior art keywords
methyl
alkyl
amino
phenyl
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60019954T
Other languages
German (de)
English (en)
Other versions
DE60019954D1 (en
Inventor
H. William MILLER
A. Kenneth NEWLANDER
A. Mark SEEFELD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affinium Pharmaceuticals Inc
Original Assignee
Affinium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinium Pharmaceuticals Inc filed Critical Affinium Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60019954D1 publication Critical patent/DE60019954D1/de
Publication of DE60019954T2 publication Critical patent/DE60019954T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Semiconductor Lasers (AREA)
DE60019954T 1999-10-08 2000-10-06 Fab i hemmer Expired - Lifetime DE60019954T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15852999P 1999-10-08 1999-10-08
US158529P 1999-10-08
PCT/US2000/027591 WO2001026654A1 (en) 1999-10-08 2000-10-06 Fab i inhibitors

Publications (2)

Publication Number Publication Date
DE60019954D1 DE60019954D1 (en) 2005-06-09
DE60019954T2 true DE60019954T2 (de) 2006-02-23

Family

ID=22568552

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60019954T Expired - Lifetime DE60019954T2 (de) 1999-10-08 2000-10-06 Fab i hemmer

Country Status (8)

Country Link
EP (1) EP1225895B1 (https=)
JP (1) JP4961084B2 (https=)
AT (1) ATE294578T1 (https=)
AU (1) AU1192501A (https=)
CO (1) CO5251401A1 (https=)
DE (1) DE60019954T2 (https=)
HK (1) HK1049610A1 (https=)
WO (1) WO2001026654A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
CO5370679A1 (es) 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
WO2001026652A1 (en) * 1999-10-08 2001-04-19 Smithkline Beecham Corporation Fab i inhibitors
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
HU230030B1 (hu) 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
US6730684B1 (en) * 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
MXPA03003039A (es) * 2000-10-06 2003-10-15 Neurogen Corp Derivados de indola y bencimidazola como moduladores del receptor crf.
EP1560584B1 (en) 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1575951B1 (en) * 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
CN101203504B (zh) * 2005-05-03 2012-11-14 兰贝克赛实验室有限公司 抗微生物剂
WO2006117762A2 (en) 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Antimicrobial agents
JP2009533315A (ja) * 2006-04-10 2009-09-17 ランバクシー ラボラトリーズ リミテッド 抗菌剤
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
CN105503869A (zh) 2011-08-10 2016-04-20 爱尔兰詹森科学公司 抗细菌的哌啶基取代的3,4-二氢-1h-[1,8]萘啶酮
US9394295B2 (en) 2011-08-10 2016-07-19 Janssen Sciences Ireland Uc Antibacterial homopiperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones
AU2013279021C1 (en) 2012-06-19 2017-03-16 Debiopharm International Sa Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
JP6250667B2 (ja) 2012-08-10 2017-12-20 ヤンセン・サイエンシズ・アイルランド・ユーシー 新しい抗菌化合物
EP2882739B1 (en) 2012-08-10 2017-05-03 Janssen Sciences Ireland UC New antibacterial compounds
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
TN2021000159A1 (en) 2019-02-14 2023-04-04 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
SG11202113174SA (en) 2019-06-14 2021-12-30 Debiopharm Int Sa Medicament and use thereof for treating bacterial infections involving biofilm

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US5932743A (en) * 1997-08-21 1999-08-03 American Home Products Corporation Methods for the solid phase synthesis of substituted indole compounds

Also Published As

Publication number Publication date
ATE294578T1 (de) 2005-05-15
EP1225895A1 (en) 2002-07-31
CO5251401A1 (es) 2003-02-28
JP2003511415A (ja) 2003-03-25
AU1192501A (en) 2001-04-23
HK1049610A1 (zh) 2003-05-23
WO2001026654A1 (en) 2001-04-19
DE60019954D1 (en) 2005-06-09
EP1225895B1 (en) 2005-05-04
EP1225895A4 (en) 2002-11-13
JP4961084B2 (ja) 2012-06-27

Similar Documents

Publication Publication Date Title
DE60019954T2 (de) Fab i hemmer
DE60016198T2 (de) Antibakterielle verbindungen
DE60029235T2 (de) Fab-i-hemmer
DE60017180T2 (de) Fab i inhibitoren
JP4676676B2 (ja) カスパーゼ阻害剤としての複素環ジカルバミド
ES2320984T3 (es) Inhibidores de fab i.
US6503903B1 (en) Fab I inhibitors
US6762201B1 (en) Fab I inhibitors
US6730684B1 (en) Fab I inhibitors
TW201536793A (zh) Ｂａｃｅ抑制劑
DE60111774T2 (de) Antibakterielle verbindungen
EP1819704B1 (en) Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase
AU2004295178A1 (en) Therapeutics use of pyridinium compounds to modulate NAADP activity
JPH10168079A (ja) 尿素誘導体
JP4189029B2 (ja) 抗けいれん剤としての未置換および置換ｎ−（ピロール−１−イル）ピリジンアミンの使用
JPH11508588A (ja) キナゾリン誘導体
HK1107984B (en) Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase
JPWO1999026925A1 (ja) 複素環式アミド化合物からなるトリプターゼ阻害剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition